Invesco Biotechnology & Genome ETF
PBE
PBE
77 hedge funds and large institutions have $53.4M invested in Invesco Biotechnology & Genome ETF in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 21
Holders
77
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.04M | |
| 2 | +$641K | |
| 3 | +$341K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$301K |
| 5 |
Neuberger Berman Group
New York
|
+$233K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$1.65M | |
| 3 | -$1.25M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$707K |
| 5 |
Jane Street
New York
|
-$568K |